Granuloma Annulare in the Setting of Secukinumab
| Autor: | Courtney A Tobin, Tricia A. Missall, Matthew L. Clark, Angela M Sutton |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty integumentary system business.industry Thyroid disease Case Report Dermatology lcsh:RL1-803 medicine.disease Malignancy 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine medicine Etiology lcsh:Dermatology Secukinumab Interleukin 17 business Dyslipidemia Histiocyte Granuloma annulare |
| Zdroj: | Case Reports in Dermatological Medicine, Vol 2018 (2018) Case Reports in Dermatological Medicine |
| ISSN: | 2090-6471 2090-6463 |
| Popis: | Granuloma annulare (GA) is a common benign inflammatory skin condition classically presenting as skin-colored to erythematous dermal papules and annular plaques. Histologically, GA displays a dermal granulomatous infiltrate with palisaded histiocytes surrounding focally altered collagen. The exactly etiology of GA remains unknown, but it has been associated with trauma, various infections, diabetes mellitus, malignancy, thyroid disease, dyslipidemia, and several medications. In 2017, a case of GA developing in a patient treated with the interleukin 17A antagonist secukinumab was reported. Here we report a second case of GA in association with secukinumab use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text